Patients with HPV-positive oropharynx cancer should receive chemoradiation

(European Society for Medical Oncology) Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to late-breaking research reported at the ESMO 2018 Congress in Munich.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news